Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study-Reference-Cited by-同舟云学术

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study

Published:2018-12 Issue:12 Volume:20 Page:1575-1582
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Girardi Fabio,Barnes Daniel R.,Barrowdale Daniel,Frost Debra,Brady Angela F.,Miller Claire,Henderson Alex,Donaldson Alan,Murray Alex,Brewer Carole,Pottinger Caroline,Evans D Gareth,Eccles Diana,Lalloo Fiona,Gregory Helen,Cook Jackie,Eason Jacqueline,Adlard Julian,Barwell Julian,Ong Kai Ren,Walker Lisa,Izatt Louise,Side Lucy E.,Kennedy M John,Tischkowitz Marc,Rogers Mark T.,Porteous Mary E.,Morrison Patrick J.,Eeles Ros,Davidson Rosemarie,Snape Katie,Easton Douglas F.,Antoniou Antonis C

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/gim201844.pdf

Reference33 articles.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight BRCA1 variants of uncertain significance by integrating available functional data with protein interaction assays;Frontiers in Oncology;2023-04-24

2. Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation;Critical Reviews in Oncology/Hematology;2022-08

3. Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country;Frontiers in Oncology;2022-07-11

4. Hereditary Breast and Ovarian Cancer;Obstetrics and Gynecology Clinics of North America;2022-03

5. Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer;Frontiers in Oncology;2021-04-06